Has trial result burst BMS' Cobenfy bubble? Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

#mentalhealth #psychiatry #BMS #Cobenfy #xanomelinetartrateandtrospiumchloride #BristolMyersSquibb #schizophrenia #schizophreniatreatment #atypicalantipsychoticmedications #schizophreniamedications #antipsychotics #ARIStrial #adjunctivetreatmentforschizophrenia
pharmaphorum.com/news/has-tri...